CONMED Corp. Stock
CONMED Corp. Stock
Heavy losses for CONMED Corp. today as the stock fell by -€1.200 (-3.700%).
Currently there is a rather positive sentiment for CONMED Corp. with 5 Buy predictions and 0 Sell predictions.
With a target price of 59 € there is a hugely positive potential of 89.1% for CONMED Corp. compared to the current price of 31.2 €.
Pros and Cons of CONMED Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | -3.700% | -10.857% | -10.857% | -53.778% | -10.857% | -64.343% | -66.452% |
| Icu Medical Inc. | -0.800% | -3.876% | 0.000% | -23.926% | 0.000% | -28.324% | -25.749% |
| Bio-Rad Labs Inc. A | -0.120% | -7.052% | -3.916% | -27.607% | -3.916% | -43.810% | -47.722% |
| Neogen Corp. | -1.720% | 3.012% | 39.024% | -22.973% | 39.024% | - | - |
Comments
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Corporation (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $80.00 to $68.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $91.00 to $61.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat